Mannel, Robert S <br/><br/>
A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study.  [electronic resource] 

 -  Gynecologic oncology  Jul 2011 
 - 89-94 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2011.03.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carboplatin--administration & dosage<br/>Carcinoma, Ovarian Epithelial<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Recurrence, Local--pathology<br/>Neoplasm Staging<br/>Neoplasms, Glandular and Epithelial--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Treatment Outcome